Business
US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
About this update from Racura Oncology Ltd
[{"type":"text","content":"Race Oncology Ltd has released a press release. View Attachment","length":239,"tagName":"div"}]